CLEC7A has been widely studied in pancreatic cancer, kidney cancer, and liver cancer, etc., but the true role of this gene remains controversial (Seifert et al., 2015; Xia et al., 2016; Daley et al., 2017). This evidence concerns the gene CLEC7A and familial pancreatic carcinoma.